Medtronic Inc

MDT-N

Analysis and Opinions about MDT-N

Signal
Opinion
Expert
HOLD
HOLD
June 22, 2016

Acquired Covidien about a year or so ago. A very synergistic acquisition. Has had a great run. A name he would absolutely continue to hold onto. Great balance sheet. Growing in their businesses. His preferred choice in medical devices.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
June 22, 2016

Acquired Covidien about a year or so ago. A very synergistic acquisition. Has had a great run. A name he would absolutely continue to hold onto. Great balance sheet. Growing in their businesses. His preferred choice in medical devices.

PAST TOP PICK
PAST TOP PICK
June 21, 2016

(A Top Pick Sept 18/15. Up 22.15%.) Their merger with Covidien has worked out well, and they successfully moved their headquarters to Ireland. There continues to be hefty chunks of cash flow that can be used for tuck in acquisitions or further dividend increases down the road.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
June 21, 2016

(A Top Pick Sept 18/15. Up 22.15%.) Their merger with Covidien has worked out well, and they successfully moved their headquarters to Ireland. There continues to be hefty chunks of cash flow that can be used for tuck in acquisitions or further dividend increases down the road.

COMMENT
COMMENT
June 14, 2016

He likes healthcare, and specifically medical devices. This company is big on implants, both for heart and minimally invasive, as well spinal implants. With an aging population, a lot of replacement parts are required, and this company is doing a great job. 1.8% dividend yield. He likes the stock.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
June 14, 2016

He likes healthcare, and specifically medical devices. This company is big on implants, both for heart and minimally invasive, as well spinal implants. With an aging population, a lot of replacement parts are required, and this company is doing a great job. 1.8% dividend yield. He likes the stock.

BUY
BUY
June 13, 2016

For 5-10 years? A good name. Basically medical devices. A very, very strong company. Well-managed. Good pipeline of products.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
June 13, 2016

For 5-10 years? A good name. Basically medical devices. A very, very strong company. Well-managed. Good pipeline of products.

COMMENT
COMMENT
June 7, 2016

Have been very heavily into pacemakers and are getting very heavily into spinal treatments. Just made an acquisition of a small company that helps out in spinal surgeries. This has been a wonderful performer over time. Free cash flow growth has been in the 13% range over the last 5 years. Dividend has been growing at roughly 9%. A nice steady stock.

Show full opinionHide full opinion

Have been very heavily into pacemakers and are getting very heavily into spinal treatments. Just made an acquisition of a small company that helps out in spinal surgeries. This has been a wonderful performer over time. Free cash flow growth has been in the 13% range over the last 5 years. Dividend has been growing at roughly 9%. A nice steady stock.

BUY
BUY
June 1, 2016

He is always very picky when it comes to medical equipment supply companies. This has been one of the major players for very long time, and is one of the better performers. You have the aging and the baby boomers. Some of the healthcare stocks have been beaten and dragged down with the Biotechs. Biotechs started to break out yesterday, which will pull up all health related companies. This has some good fundamentals.

Show full opinionHide full opinion

He is always very picky when it comes to medical equipment supply companies. This has been one of the major players for very long time, and is one of the better performers. You have the aging and the baby boomers. Some of the healthcare stocks have been beaten and dragged down with the Biotechs. Biotechs started to break out yesterday, which will pull up all health related companies. This has some good fundamentals.

TOP PICK
TOP PICK
May 25, 2016

Cardiac implants, spinal implants and diabetes devices. A play on the secular theme of spending on healthcare. They are all about scale. It is fundamentally very attractive. They have a dominant role and can save the system money with their implants.

Show full opinionHide full opinion

Cardiac implants, spinal implants and diabetes devices. A play on the secular theme of spending on healthcare. They are all about scale. It is fundamentally very attractive. They have a dominant role and can save the system money with their implants.

TOP PICK
TOP PICK
May 13, 2016

Medical implants. A play on the aging population. About 1.5 years ago, they took out the old Tyco division called Covidien, their healthcare business. Covidien had got to Ireland, and this company now has done the inversion. This company is now sitting on boatloads of cash globally. We are going to see higher dividends, share buybacks and probably more acquisitions. Target price of $88.

Show full opinionHide full opinion

Medical implants. A play on the aging population. About 1.5 years ago, they took out the old Tyco division called Covidien, their healthcare business. Covidien had got to Ireland, and this company now has done the inversion. This company is now sitting on boatloads of cash globally. We are going to see higher dividends, share buybacks and probably more acquisitions. Target price of $88.

COMMENT
COMMENT
October 1, 2015

60% of his assets are outside of Canada and he is comfortable with that. He looked at it and decided it was expensive. It is starting to come down.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
October 1, 2015

60% of his assets are outside of Canada and he is comfortable with that. He looked at it and decided it was expensive. It is starting to come down.

TOP PICK
TOP PICK
September 18, 2015

(A Top Pick July 18/14. Up 14.85%.) Acquired Covidian at about $43 billion, and moved their headquarters to Dublin Ireland for lower taxes. The acquisition transforms them into the largest medical device company globally. It also gives them line of sight to be more significant in emerging markets, as well as general surgical tools. Dividend yield of 2.16%.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
September 18, 2015

(A Top Pick July 18/14. Up 14.85%.) Acquired Covidian at about $43 billion, and moved their headquarters to Dublin Ireland for lower taxes. The acquisition transforms them into the largest medical device company globally. It also gives them line of sight to be more significant in emerging markets, as well as general surgical tools. Dividend yield of 2.16%.

COMMENT
COMMENT
August 13, 2015

This is the one part of the health market that has seen pressure on the pricing side. As hospitals get together and form bigger consortiums, they are able to exert a bit of pressure. When people look at the margins in this area, they feel that maybe they don’t have to be so high. For some of their products, if it is differentiated enough, you could have a little bit of pricing, but there is quite a bit of product of that can be replaced by generics and this is what is happening. She would like to see this start improving and reversing before she got constructive on the name.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
August 13, 2015

This is the one part of the health market that has seen pressure on the pricing side. As hospitals get together and form bigger consortiums, they are able to exert a bit of pressure. When people look at the margins in this area, they feel that maybe they don’t have to be so high. For some of their products, if it is differentiated enough, you could have a little bit of pricing, but there is quite a bit of product of that can be replaced by generics and this is what is happening. She would like to see this start improving and reversing before she got constructive on the name.

PARTIAL SELL
PARTIAL SELL
May 7, 2015

This has been doing tremendously well. They do have a lot of debt, and their debt load is a little bit scary for him. If he owned this, he would be thinking of paring back or selling. We are also moving into that time of the year when stocks do not do that well.

Show full opinionHide full opinion

This has been doing tremendously well. They do have a lot of debt, and their debt load is a little bit scary for him. If he owned this, he would be thinking of paring back or selling. We are also moving into that time of the year when stocks do not do that well.

BUY
BUY
January 8, 2015

$80.49 model price, 10% upside. He is positive on it and would buy it here.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
January 8, 2015

$80.49 model price, 10% upside. He is positive on it and would buy it here.

BUY WEAKNESS
BUY WEAKNESS
December 9, 2014

Likes the space they are in. It is knees and spines, which plays into the aging demographic’ profile, and as the US and other economies improve, that will be directed into some of these areas as a somewhat discretionary spend. Prefers Johnson & Johnson (JNJ-N) which has the medical devices division. If their acquisition goes through, it will be a positive. She would wait for it to pull back a little.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
December 9, 2014

Likes the space they are in. It is knees and spines, which plays into the aging demographic’ profile, and as the US and other economies improve, that will be directed into some of these areas as a somewhat discretionary spend. Prefers Johnson & Johnson (JNJ-N) which has the medical devices division. If their acquisition goes through, it will be a positive. She would wait for it to pull back a little.

COMMENT
COMMENT
August 5, 2014

(Market Call Minute.) Loves the health care in the US. He is playing this through C. R. Bard (BCR-N) and Zimmer (ZMH-N).

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
August 5, 2014

(Market Call Minute.) Loves the health care in the US. He is playing this through C. R. Bard (BCR-N) and Zimmer (ZMH-N).

COMMENT
COMMENT
July 25, 2014

Used to be a dividend aristocrat in that it paid an increasing dividend every single year, for a long period of time. Good balance sheet, leveraged to the tool market in the medical space. Somewhat slower growth during the recession. They are acquiring Covidien (COV-N) and will re-base in Ireland giving them lower taxes. This will accelerate their growth. Longer-term, if you buy the story, you’ll be okay, but it is a multi-year story. A slow growth story.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
July 25, 2014

Used to be a dividend aristocrat in that it paid an increasing dividend every single year, for a long period of time. Good balance sheet, leveraged to the tool market in the medical space. Somewhat slower growth during the recession. They are acquiring Covidien (COV-N) and will re-base in Ireland giving them lower taxes. This will accelerate their growth. Longer-term, if you buy the story, you’ll be okay, but it is a multi-year story. A slow growth story.

TOP PICK
TOP PICK
July 18, 2014

On the cusp of a transformational acquisition, the $43 billion purchase of Covidian (COV-N). This changes their headquarters with a tax inversion deal, making Covidian a 30% owner of the new Medtronic. In order for a tax inversion to take place, you have to own at least 20%, so maybe the extra buffer of 30% will appease regulators, and keep everybody happy. This would allow them to have foreign profit, somewhere in the realm of about $14 billion, and be able to re-disperse them among their existing shareholders. A good line of sight for a growing dividend, further share buybacks, as well as future tuck in acquisitions. This deal would make them the biggest and most diversified medical devices company globally. Also, developing a series of new products. Yield of 1.97%.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
July 18, 2014

On the cusp of a transformational acquisition, the $43 billion purchase of Covidian (COV-N). This changes their headquarters with a tax inversion deal, making Covidian a 30% owner of the new Medtronic. In order for a tax inversion to take place, you have to own at least 20%, so maybe the extra buffer of 30% will appease regulators, and keep everybody happy. This would allow them to have foreign profit, somewhere in the realm of about $14 billion, and be able to re-disperse them among their existing shareholders. A good line of sight for a growing dividend, further share buybacks, as well as future tuck in acquisitions. This deal would make them the biggest and most diversified medical devices company globally. Also, developing a series of new products. Yield of 1.97%.

BUY
BUY
February 7, 2014

Is this a good time to get into health care stocks and what would you recommend? Likes Abbott Labs (ABT-N) very much. Spun off their pharmaceutical R&D business about 2 years ago and split themselves up into 4 different divisions. If looking at global healthcare companies, you can’t go wrong with something like Johnson & Johnson (JNJ-N). Products are cheap and they can easily raise costs. Also likes Medtronics (MDT-N) which is a device manufacturer.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
February 7, 2014

Is this a good time to get into health care stocks and what would you recommend? Likes Abbott Labs (ABT-N) very much. Spun off their pharmaceutical R&D business about 2 years ago and split themselves up into 4 different divisions. If looking at global healthcare companies, you can’t go wrong with something like Johnson & Johnson (JNJ-N). Products are cheap and they can easily raise costs. Also likes Medtronics (MDT-N) which is a device manufacturer.

COMMENT
COMMENT
August 21, 2013

Likes the company and if you are comfortable with this, he thinks the medical device space is very positive demographically. You could hold this for the longer-term.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
August 21, 2013

Likes the company and if you are comfortable with this, he thinks the medical device space is very positive demographically. You could hold this for the longer-term.

SELL
SELL
November 9, 2012

Done well, constantly makes money. Incredible debt load relative to revenues. Insiders have not really been selling. Great company and pays a nice dividend but he would be looking to sell it - next year to defer tax.

Show full opinionHide full opinion
Medtronic Inc (MDT-N)
November 9, 2012

Done well, constantly makes money. Incredible debt load relative to revenues. Insiders have not really been selling. Great company and pays a nice dividend but he would be looking to sell it - next year to defer tax.

BUY
BUY
October 18, 2010
(Market Call Minute) Suffered from litigation, but great technology and dominant market share in many areas.
Show full opinionHide full opinion
Medtronic Inc (MDT-N)
October 18, 2010
(Market Call Minute) Suffered from litigation, but great technology and dominant market share in many areas.
BUY
BUY
September 15, 2010
Well run leader in global medical technology including diagnostic testing and medical equipment used in surgeries. 25-year history of increasing dividends annually. Strong Cdn$ makes it an attractive buy. Good entry point.
Show full opinionHide full opinion
Medtronic Inc (MDT-N)
September 15, 2010
Well run leader in global medical technology including diagnostic testing and medical equipment used in surgeries. 25-year history of increasing dividends annually. Strong Cdn$ makes it an attractive buy. Good entry point.
PAST TOP PICK
PAST TOP PICK
August 17, 2010
(A Top Pick Apr 21/09. Up 18.59%.) Sold out at a substantially higher price and made at least 50%.
Show full opinionHide full opinion
Medtronic Inc (MDT-N)
August 17, 2010
(A Top Pick Apr 21/09. Up 18.59%.) Sold out at a substantially higher price and made at least 50%.
PAST TOP PICK
PAST TOP PICK
July 8, 2010
(A Top Pick Apr 21/09. Up 24.54%.) Sold his holdings but has now come down nicely and maybe in his portfolio next month.
Show full opinionHide full opinion
(A Top Pick Apr 21/09. Up 24.54%.) Sold his holdings but has now come down nicely and maybe in his portfolio next month.
PAST TOP PICK
PAST TOP PICK
May 27, 2010
(A Top Pick April 21/09. Up 30.27%.) Either came close to his model price or he found something of more value so he sold his holdings.
Show full opinionHide full opinion
(A Top Pick April 21/09. Up 30.27%.) Either came close to his model price or he found something of more value so he sold his holdings.
PAST TOP PICK
PAST TOP PICK
April 1, 2010
(A Top Pick April 21/09. Up 49.77%.) Sold his holdings at a good gain.
Show full opinionHide full opinion
Medtronic Inc (MDT-N)
April 1, 2010
(A Top Pick April 21/09. Up 49.77%.) Sold his holdings at a good gain.
PAST TOP PICK
PAST TOP PICK
February 3, 2010
(A Top Pick Feb 24/09. Up 30.52%.)
Show full opinionHide full opinion
Medtronic Inc (MDT-N)
February 3, 2010
(A Top Pick Feb 24/09. Up 30.52%.)
BUY
BUY
August 13, 2009
Likes med-tech space. Space has historically traded at 20 PE’s and up. Growth is very good. Demographics are very positive. Currently out of favour because of fears of what the government will do to the industry. Trading at one of the lowest multiples in its 20-year history.
Show full opinionHide full opinion
Medtronic Inc (MDT-N)
August 13, 2009
Likes med-tech space. Space has historically traded at 20 PE’s and up. Growth is very good. Demographics are very positive. Currently out of favour because of fears of what the government will do to the industry. Trading at one of the lowest multiples in its 20-year history.
TOP PICK
TOP PICK
Medtronic Inc (MDT-N)
April 21, 2009
Model $42.48.
TOP PICK
TOP PICK
February 24, 2009
He has a model price of $41.29 giving it a 21% positive differential. Just reported greater earnings. 2% yield.
Show full opinionHide full opinion
Medtronic Inc (MDT-N)
February 24, 2009
He has a model price of $41.29 giving it a 21% positive differential. Just reported greater earnings. 2% yield.
Showing 31 to 60 of 79 entries